|
|
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
|
2R42CA203456-02A1
|
$999,501
|
|
MARATHI, UPENDRA
|
7 HILLS PHARMA, LLC
|
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-04
|
$1,917,582
|
$479,396
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
The role of macroH2A variants in cancer and senescence
|
1R01CA155232-01A1
|
$346,179
|
$346,179
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$112,723
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$7,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$7,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$2,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$4,070
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
5R01CA133010-04
|
$395,050
|
$197,525
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Skp2 in androgen-dependent proliferation of prostate cancer cells
|
5R01CA127901-04
|
$300,705
|
$60,141
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-21
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
MOTILITY AND INVASION
|
5P01CA100324-16
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-08
|
$382,013
|
$382,013
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-05
|
$346,525
|
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
|
1R01CA226861-01
|
$382,013
|
|
MACIAN, FERNANDO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-04
|
$264,583
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
5R01CA218429-02
|
$1,347,851
|
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis
|
5R01CA201458-03
|
$382,013
|
|
ZHU, LIANG
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
5UG1CA189958-05
|
$666,396
|
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
5R44CA183362-03
|
$789,107
|
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$404,941
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$20,674
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$1,549,807
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Synergistic Anti-tumor Efficacy of an Interleukin 2 Analog and PD-1 blockade
|
1R43CA228319-01
|
$299,794
|
|
CHEN, RIDONG
|
APT THERAPEUTICS, INC.
|
|
|
Stand and Move at Work: A Group-Randomized Trial
|
5R01CA198971-04
|
$582,484
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-04
|
$492,377
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
|
1R01CA162393-01A1
|
$639,914
|
$639,914
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Geospatial Factors and Impacts II
|
2R01CA126858-05
|
$403,837
|
$403,837
|
MOBLEY, LEE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-03
|
$378,392
|
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-05
|
$315,400
|
|
HORUZSKO, ANATOLIJ
|
AUGUSTA UNIVERSITY
|
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-03
|
$29,664
|
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-23
|
$556,510
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
|
IDO-Expressing Immunoregulatory Dendritic Cells
|
5R01CA103320-15
|
$307,800
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
5R01CA202769-03
|
$397,877
|
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-03
|
$1,063,923
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$19,447
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Functional Genomics and Precision Therapy Testing for Langerhans Cell Histiocytosis
|
1F31CA228360-01
|
$44,524
|
|
BURKE, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
3R01CA190776-04S1
|
$116,456
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
|
5U01CA214125-02
|
$1,413,657
|
|
ELLIS, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
|
5R01CA072038-20
|
$320,963
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Advanced glycation end products and colorectal cancer risk in women
|
5R03CA156626-02
|
$80,193
|
$40,097
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer
|
5R03CA212816-02
|
$79,250
|
|
KAIPPARETTU, BENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-04
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer
|
5R01CA220297-02
|
$365,246
|
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Aging for this search: $94,073,054
|
